Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT05739929
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT05739929
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Unknown status
Technical summary
Registry record NCT05739929. Randomized; quadruple masking; primary purpose treatment. Start 2023-03-01 (actual); primary completion 2024-08-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Colchicine 0.5 MG Oral Tablet
- Intervention (Drug)
- Placebo
- Lead sponsor
- Helwan University
Record details
- Record id
cardio:ct-nct05739929- Content hash
c0203912cbc4ff05c75bdda1fde560d176974b726efb6e7f6debd446e1d072f5